BGN-25

BGN-25 is an investigational **topical biologic ointment** listed in Biogenomics's pipeline for **diabetic foot ulcers**. Publicly available source material provided here identifies the asset only by the code name BGN-25 and formulation/route context, with no disclosed molecular identity, target, or detailed mechanism of action. Based on the available evidence, it appears to be a locally applied biologic wound-healing candidate intended for treatment of diabetic foot ulcers, but its active ingredient, pharmacology, and development stage have not been clearly described in the accessible source material.

Other names

BGN-25 Biogenomics topical ointmentBGN25 Biogenomics topical ointmentBGN 25 Biogenomics topical ointment